Satsuma Pharmaceuticals is a pharmaceutical company that develops and commercializes novel therapies for the treatment of migraine. The company's lead product candidate, STS101, is a drug-device combination product that is designed to provide fast and sustained relief from migraine. The company is focused on developing products that are easy to use and have a rapid onset of action.